证券代码：301223 证券简称：中荣股份 公告编号：2025-034 中荣印刷集团股份有限公司 关于股份回购进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 中荣印刷集团股份有限公司（以下简称"公司"）于 2024 年 9 月 2 日召开 第三届董事会第十六次会议，审议通过了《关于回购公司股份方案的议案》，同 意公司使用自有资金以集中竞价交易方式回购公司发行的部分人民币普通股（A 股）股票（以下简称"本次回购"），在未来适宜时机将回购股份用于股权激励 计划或员工持股计划。本次用于回购的资金总额不低于人民币 2,500 万元（含）， 不超过人民币 5,000 万元（含），回购价格不超过 22.12 元/股（含），实施期限 为自公司董事会审议通过本次回购股份方案之日起 12 个月内。具体内容详见公 司刊登于巨潮资讯网（www.cninfo.com.cn）的《关于回购公司股份方案的公告》 （公告编号：2024-053）、《回购报告书》（公告编号：2024-055）。 鉴于公司 2024 年年度权益分派方案的实施，根据相关规定，公司自权益分 派除权除息之日 ...

证券代码：301223 证券简称：中荣股份 公告编号：2025-033 一、回购股份的基本情况 中荣印刷集团股份有限公司（以下简称"公司"）于2024年9月2日召开第三 届董事会第十六次会议，审议通过了《关于回购公司股份方案的议案》，同意公 司使用自有资金以集中竞价交易方式回购公司发行的部分人民币普通股（A股） 股票（以下简称"本次回购"），在未来适宜时机将回购股份用于股权激励计划 或员工持股计划。本次用于回购的资金总额不低于人民币2,500万元（含），不超 过人民币5,000万元（含），回购价格不超过22.12元/股（含），实施期限为自公 司董事会审议通过本次回购股份方案之日起12个月内。具体内容详见公司刊登于 巨潮资讯网（www.cninfo.com.cn）的《关于回购公司股份方案的公告》（公告编 号：2024-053）及《回购报告书》（公告编号：2024-055）。 二、调整回购股份价格上限的原因 中荣印刷集团股份有限公司 关于2024年年度权益分派实施后调整回购股份价格上限的 公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、调 ...

北京市中伦（深圳）律师事务所 关于中荣印刷集团股份有限公司 2024 年度股东大会的 法律意见书 二〇二五年五月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 本所律师根据《股东会规则》的要求，依照律师行业公认的业务标准、道 德规范及勤勉尽责精神，对公司提供的相关文件和有关事实进行了核查和验证， 现出具如下法律意见： 一、 本次股东大会的召集和召开程序 （一） 本次股东大会的召集 为召开本次股东大会，公司董事会于 2025 年 4 月 24 日在巨潮资讯网 北京市中伦（深圳）律师事务所 关于中荣印刷 ...

证券代码：301223 证券简称：中荣股份 公告编号：2025-031 中荣印刷集团股份有限公司 2024年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决提案的情况。 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、会议召开的时间 现场会议时间：2025 年 5 月 16 日（星期五）15:00 网络投票时间：2025 年 5 月 16 日（星期五） 通过深圳证券交易所（以下简称"深交所"）交易系统投票的时间为 2025 年 5 月 16 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深交所互联网投票系统 （http://wltp.cninfo.com.cn）投票的时间为 2025 年 5 月 16 日 9:15-15:00。 2、会议召开地点：广东省中山市火炬开发区沿江东三路 28 号 3、会议召开方式：会议采用现场表决与网络投票相结合的方式召开 4、会议召集人：公司董事会 5、会议主持人：公司董事长黄焕然先生因个人原因未能出席和主持本次股 东 ...

Core Viewpoint - Zhongrong Co., Ltd. (301223.SZ) announced that its actual controller, chairman, and general manager Huang Huanran has been placed under residential surveillance by the Zhongshan Public Security Bureau, which casts a shadow over the company's already fragile investor reputation amid declining performance and long-term stock price underperformance [2][10]. Company Performance - The company's main business is the research, production, and sales of paper printing and packaging products, with key products including folding color boxes (71.54% of revenue), gift boxes (11.99%), and color cartons [5]. - From 2018 to 2022, the company's revenue showed a growth trend, with figures of 1.886 billion, 2.063 billion, 2.177 billion, 2.544 billion, and 2.473 billion respectively, while net profit attributable to shareholders was 118 million, 175 million, 186 million, and 212 million [7]. - However, post-listing, the company's performance began to decline, with net profit attributable to shareholders projected to be 204 million and 144 million for 2023 and 2024, representing year-on-year declines of 4.4% and 29.6% respectively [9]. Financial Metrics - The company's gross margin decreased from 22.41% in 2022 to 18.31% in 2024, attributed to declining sales prices and the lack of scale effects from new product lines [9]. - In 2024, the company's operating cash flow net amount was 267 million, down 12.43% year-on-year, with accounts receivable increasing by 51.19% to 960 million [9]. Stock Performance and Investor Sentiment - Since its IPO in October 2022, Zhongrong's stock has consistently underperformed, opening at 26.28 yuan but immediately falling below the issue price, leading to ongoing investor complaints about the stock's performance [10]. - Despite the company implementing buyback and dividend strategies, the effectiveness of these measures remains uncertain, with only 13.11 million repurchased against a plan of 25 million to 50 million [10][11]. - The company has distributed over 150 million in dividends from 2022 to 2024, but most of this has benefited the two largest shareholders, who hold over 70% of the shares [11]. Acquisition Strategy - In July of the previous year, the company acquired 70% of Mozihua Printing Co., Ltd. for 192 million, claiming it would enhance market responsiveness and competitiveness [11]. - Despite a 27.5% year-on-year increase in revenue to 699 million in the first quarter, the net profit attributable to shareholders fell by 4.67%, indicating a situation of revenue growth without profit improvement [11].

5月13日晚，中荣股份（301223）（301223.SZ）发布公告称，公司近日收到公司实控人、董事长兼总经 理黄焕然家属的通知，黄焕然被中山市公安局指定居所监视居住。 中荣股份的主要业务包括纸制印刷包装产品的研发、设计、生产和销售，为国内外不同行业的客户提供 创新研发、创意设计、色彩管理、智能化生产、供应链管理、终端营销服务及其他个性化需求配套解决 方案服务。公司于2022年10月在深交所创业板上市。 2024年，中荣股份实现营业收入27.82亿元，同比增长7.30%；归股净利润为1.44亿元，同比下降 29.60%。 公开资料显示，中荣股份2023年被国家新闻出版广电总局评选为"国家印刷示范企业"，中山新工厂2018 年被国家工业和信息化部评为"智能制造试点示范（高档纸制品包装智能制造）"项目、被国家新闻出版 署评选为"印刷智能制造试点示范"项目，2020年被国家工业和信息化部评为"国家绿色工厂""国家绿色 供应链管理企业"。 5月14日，中荣股份开盘走低，截至午间收盘跌8.31%，报15.45元/股，总市值29.84亿元。 一周前还参与业绩说明会 中荣股份表示，目前，公司已对相关工作进行了妥善安排，除黄 ...

Group 1: 华峰化学 - Company decided to terminate the acquisition of 100% equity in Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. due to insufficient shareholder approval [1] - The decision was made based on prudence, as the proposal did not receive more than two-thirds of the valid voting rights at the shareholders' meeting [1] - Company will continue to promote related equity injection work and strictly fulfill asset injection commitments [1] Group 2: 中荣股份 - Actual controller and chairman Huang Huanran has been placed under residential surveillance by the police [2] - Other board members and senior management are performing their duties normally, and the board of directors is operating as usual [2] - Company specializes in the research, design, production, and sales of paper printing and packaging products [2] Group 3: 密尔克卫 - Three shareholders plan to reduce their holdings by a total of up to 2% of the company's shares through block trading [3] - The reduction includes 143.63 million shares, 97.65 million shares, and 75.03 million shares, representing 0.91%, 0.62%, and 0.47% of the total share capital respectively [3] - The reduction period is from June 6, 2025, to September 5, 2025, due to personal funding needs [3] Group 4: 舒泰神 - Subsidiary Jiangsu Beijietai Biotechnology Co., Ltd. has obtained a drug production license from the Jiangsu Provincial Drug Administration [4] - The license allows for the production of therapeutic biological products, specifically for registered declaration use [4] - The license is valid until May 7, 2030, and is not expected to have a significant impact on the company's current performance [4] Group 5: 捷顺科技 - Company won the bid for the "Chongqing Beautiful Sunshine Home and other public rental housing supporting parking space operation project" [5] - The project includes four public rental housing supporting parking lots with a total of 13,335 parking spaces [5] - The minimum guaranteed revenue for the project is quoted at 40.43 million yuan per year, with a total contract amount expected to exceed 100 million yuan [5] Group 6: 综艺股份 - Company signed an investment cooperation intention agreement to acquire control of Jiangsu Jilai Microelectronics Co., Ltd. through cash capital increase or share transfer [6] - Jilai Micro primarily engages in the research, production, and sales of power semiconductor chips and devices [6] - The transaction is expected to constitute a major asset restructuring [6] Group 7: 东山精密 - Subsidiary DSBJ PTE. LTD. plans to acquire 100% equity of French GMD Group for approximately 100 million euros (about 814 million yuan) [7] - The acquisition aims to advance the company's globalization strategy and enhance its market share in the automotive parts sector [7] - The company specializes in the research, production, and sales of electronic circuit products and precision components [7] Group 8: 诺诚健华 - Company reported a net profit of 17.97 million yuan for the first quarter of 2025, a significant turnaround from a loss of 142 million yuan in the same period last year [8] - The first quarter revenue reached 381 million yuan, representing a year-on-year growth of 129.92% [8] - The company focuses on the research, production, and commercialization of innovative drugs [8] Group 9: 凯美特气 - Shareholders plan to reduce their holdings by up to 3% of the company's shares through centralized bidding and/or block trading [9] - The total number of shares to be reduced is 20.86 million [9] - The reduction is due to personal funding needs [9] Group 10: 海创药业 - Controlling shareholder plans to reduce holdings by up to 2% of the company's shares through centralized bidding and block trading [10] - The total number of shares to be reduced is 1.98 million [10] - The reduction is due to personal funding needs [10] Group 11: 高争民爆 - Controlling shareholder plans to reduce holdings by up to 3% of the company's shares through centralized bidding and block trading [11] - The total number of shares to be reduced is 828,000 [11] - The reduction is due to the company's funding needs [11] Group 12: 金埔园林 - Two shareholders plan to reduce their holdings by a total of up to 1.91% of the company's shares [12] - The reductions include 183.93 million shares and 167.73 million shares [12] - The reasons for the reductions are asset optimization and personal funding needs [12] Group 13: 掌趣科技 - The largest shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding or block trading [13] - The total number of shares to be reduced is 27.2 million [13] - The reduction is due to personal funding needs [13] Group 14: 美凯龙 - Company announced that its director and general manager has been placed under investigation and detention by the local supervisory committee [14] - Other board members and senior management are performing their duties normally, and daily operations are unaffected [14] - The company specializes in managing and operating self-operated and franchised shopping malls [14] Group 15: 新强联 - Major shareholder plans to reduce holdings by up to 1.89% of the company's shares through centralized bidding and block trading [15] - The total number of shares to be reduced is 717,490 [15] - The reduction is due to operational needs [15] Group 16: 日月明 - Shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding [16] - The total number of shares to be reduced is 80,000 [16] - The reduction is due to personal funding needs [16] Group 17: 同有科技 - Major shareholder and vice president plan to reduce their holdings by up to 1.53% of the company's shares [17] - The total number of shares to be reduced is 730,850 [17] - The reduction is due to personal funding needs [17] Group 18: 爱尔眼科 - Subsidiary successfully acquired 60% equity and specific debt of Shenzhen Guangsheng Digital Technology Co., Ltd. for 650 million yuan [18] - The transaction constitutes a related party transaction [18] - The acquired asset will serve as long-term medical premises for the subsidiary [18]

Core Viewpoint - The actual controller of Zhongrong Co., Ltd., Huang Huanran, has been placed under residential surveillance by the police, marking the second case of such an event in A-shares this year, following *ST Dayao [1][3] Company Overview - Zhongrong Co., Ltd. primarily focuses on paper-based printing and packaging products, serving clients across various sectors including cosmetics, oral care, personal and household care, food, health products, pharmaceuticals, consumer electronics, tobacco, and alcoholic beverages [1][4] Recent Developments - Huang Huanran, the actual controller and CEO, was notified of his residential surveillance on May 13, 2023, and had participated in a performance briefing just a week prior [2][3] - The company has stated that other board members and senior management are continuing their duties normally, and the operational management remains unaffected [2][4] Financial Performance - In the previous year, Zhongrong Co., Ltd. reported revenue of 2.782 billion yuan, a year-on-year increase of 7.3%, while net profit was 144 million yuan, reflecting a year-on-year decline of 29.6% [4] - Investors have expressed dissatisfaction with the company's market value management, particularly in light of the significant drop in stock price despite relatively stable performance [4] Future Growth Strategies - The company aims to maintain its leading position in the daily chemical, food, and health product sectors while accelerating the development of production bases for tobacco and alcoholic beverage packaging [5] - There is a focus on increasing investment in the southwestern production base and expanding into key clients within these sectors to foster new business growth points [5]

Key Points - Zhongrong Co., Ltd.'s actual controller and chairman Huang Huanran has been placed under residential surveillance by the police, but other board members and management are functioning normally [3] - Donghu Gaoxin has decided to terminate its equity acquisition due to failure to meet preconditions outlined in the intention agreement, with no formal acquisition agreement signed and no payments made [4][5] - BeiGene reported a net loss of 94.503 million yuan in Q1 2025, a significant reduction from a loss of 1.908 billion yuan in the same period last year, while revenue increased by 50.2% to 8.048 billion yuan [6] - Zhejiang Rongtai's shareholders and directors plan to reduce their holdings by up to 1.93% of the company's shares through various trading methods [7] - Huanghe Xuanfeng's controlling shareholder plans to increase its stake in the company by investing between 100 million and 200 million yuan, with a loan commitment from Ping An Bank [8] - Wanxiang Denong's controlling shareholder intends to increase its stake by investing between 25 million and 50 million yuan within 12 months [9] - Hainan Huatie plans to repurchase shares worth between 200 million and 300 million yuan, with a maximum repurchase price of 15.95 yuan per share [10][11]